Država: Južnoafrička Republika
Jezik: engleski
Izvor: South African Health Products Regulatory Authority (SAHPRA)
Lennon
INDICATIONS [/za_1324.html#1] [/za_1324.html#1] [/za_1324.html#1] CONTRA-INDICATIONS [/za_1324.html#1] [/za_1324.html#1] DOSAGE [/za_1324.html#1] [/za_1324.html#1] SIDE-EFFECTS [/za_1324.html#1] [/za_1324.html#1] PREGNANCY [/za_1324.html#1] OVERDOSE [/za_1324.html#1] IDENTIFICATION [/za_1324.html#1] [/za_1324.html#1] PATIENT INFORMATION INTRAMED HYDROCORTISONE SODIUM SUCCINATE INJECTION 100 MG INTRAMED HYDROCORTISONE SODIUM SUCCINATE INJECTION 500 MG SCHEDULING STATUS: S4 PROPRIETARY NAME: (and dosage form) INTRAMED HYDROCORTISONE SODIUM SUCCINATE INJECTION 100 MG INTRAMED HYDROCORTISONE SODIUM SUCCINATE INJECTION 500 MG COMPOSITION: 100 mg HYDROCORTISONE as sodium succinate. 500 mg Hydrocortisone as sodium succinate. Diluent containing 0,5% Benzyl alcohol as bacteriostat. PHARMACOLOGICAL CLASSIFICATION: A.21.5.1 –Corticosteroids and analogues. A.34 –Others –Diluent PHARMACOLOGICAL ACTION: Hydrocortisone sodium succinate acts by controlling the rate of protein synthesis. It forms a steroid-receptor complex with receptor proteins, moves into the nucleus where it binds the chromatin and thus directs the genetic apparatus to transcribe RNA. It also delays the mineralocorticoid activity. INDICATIONS: As substitution therapy in the treatment of adrenal insufficiency states, where high levels of hydrocortisone are required rapidly. In patients with known or suspected adrenal insufficiency prior to surgery, or if shock, severe trauma or other stress conditions occur. Hydrocortisone sodium succinate is also used for the symptomatic relief of inflammatory conditions and as an immunosuppressant. CONTRA-INDICATIONS: Hypersensitivity to corticosteroids. Tuberculosis. Ocular herpes simplex. Primary glaucoma. Acute psychosis and psychoneurosis. Systemic infection. Peptic ulcer. Osteoporosis. W Pročitajte cijeli dokument